Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|April 13, 2024
Tumor Microenvironment: Cellular Interaction and Metabolic AdaptationsMonica Benvenuto, Chiara Focaccetti
Seminars in Cancer Biology|November 8, 2019
Tumor antigens heterogeneity and immune response-targeting neoantigens in breast cancerMonica Benvenuto, Chiara Focaccetti, Valerio Izzi, et al.
Frontiers in Immunology|June 26, 2023
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapyLoredana Cifaldi, Ombretta Melaiu, Roberto Giovannoni, et al.
International Journal of Molecular Sciences|November 21, 2020
PlGF Immunological Impact during PregnancyLoredana Albonici, Monica Benvenuto, Chiara Focaccetti, et al.
Biomedicines|June 28, 2023
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor InvasionValeria Lucarini, Daniela Nardozi, Valentina Angiolini, et al.
Current Opinion in Pharmacology|September 14, 2021
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of T<sub>H</sub>1 and T<sub>H</sub>2 cellsMonica Benvenuto, Chiara Focaccetti, Sara Ciuffa, et al.
International Journal of Molecular Sciences|April 10, 2019
Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?Chiara Focaccetti, Valerio Izzi, Monica Benvenuto, et al.
Frontiers in Medicine|February 23, 2023
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinomaCamilla Palumbo, Monica Benvenuto, Chiara Focaccetti, et al.
Frontiers in Immunology|August 15, 2022
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells <i>in vitro</i>: a proof-of-concept studyChiara Focaccetti, Monica Benvenuto, Chiara Pighi, et al.
Pharmacology & Therapeutics|October 12, 2020
Targeting the tumor immune microenvironment with "nutraceuticals": From bench to clinical trialsLaura Masuelli, Monica Benvenuto, Chiara Focaccetti, et al.
Pageof 8